Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0020538 (hypertension)
 170,190 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

An exercise-mediated renal omicron-iodohippurate transport abnormality was recently identified in patients with hypertension. The disturbance was not observed in normotensive controls. To learn more about this transient functional disturbance of the kidney, we obtained gamma camera hippurate renograms in 45 patients with hypertension. The final diagnoses indicated that 27 patients had essential hypertension, 15 had renal parenchymal or renovascular hypertension, 2 had malignant hypertension, and 1 had hypertension of pregnancy. We documented age, height, weight, global and unilateral renal function, blood pressure status, and antihypertensive medication used at time of scintigraphy. We also noted the serum catecholamine, sodium, and potassium levels. All patients were scintigraphed at rest and during exercise. The scintigraphic examination documented exercise-induced renal dysfunction in 28 (62%) patients (abnormal exercise renogram), while 17 (38%) had renograms not noticeably influenced by the exercise protocol (normal exercise renogram). When the results of scintigraphy were compared with the clinical data, a weak correlation was found between patient overweight and an abnormal response to exercise. There was no significant difference between groups with normal and abnormal exercise renograms with respect to the other parameters assessed. Exercise renography was not useful for differentiating renal and essential hypertension. Renography appears to demonstrate an exercise-mediated, transient, renal perfusion disturbance in certain patients with hypertension. The examination appears to assess a new parameter in hypertensive disease. Thus, the gamma camera renogram should be reevaluated in the patient with hypertension.
Hypertension 1987 Sep
PMID:Clinical evaluation of patients with hypertension and exercise-induced renal dysfunction. 362 82

We examined 82 patients 12 to 43 (mean 22) months after renal calculi had been removed by ultrasonic lithotripsy. Recurrence was noted in 2 patients but this correlated to the previous stone-forming rate. Smaller fragments that had remained in 9 patients were passed in 2, removed percutaneously in 2 and unchanged in the remainder. There was no evidence of hypertension or urinary tract infection related to the procedure. There were 62 patients available for computerized tomography and 11 per cent of the kidneys showed minute calcifications not visible on plain films. Barely visible scarring was noted on the fibrous capsule posterior to the lower pole in 22 per cent of the cases and on the abdominal wall along the former nephrostomy tract in 46 per cent. However, a cortical scar was noted in only 1 kidney and no arteriovenous fistulas were found. On dimercapto-succinic acid scans it was impossible to localize the puncture site and serial 131iodine-hippurate renograms available in 18 patients showed a 7.6 plus or minus 2.8 per cent (mean plus or minus standard error of mean) increase in function. We conclude that percutaneous nephrolithotripsy with ultrasound is a safe and effective procedure with minimal late morbidity.
 ...
PMID:Late sequelae of ultrasonic lithotripsy of renal calculi. 396 25

A patient is described who had accelerated hypertension and unilateral renal artery stenosis, and who developed further deterioration in renal function during treatment with captopril, an angiotension-I (AI) converting-enzyme inhibitor. 99mTc-DMSA uptake was greatly diminished in the stenotic kidney, although renal blood flow and handling of 131I-hippurate was preserved. Uptake of 99mTc-DMSA in the affected kidney returned after substitution of captopril by the vasodilator minoxidil, while a comparable degree of blood pressure control was maintained. Thus, caution must be taken when interpreting results of 99mTc-DMSA scintigraphy in patients with proven or suspected renal artery stenosis treated with an AI converting-enzyme inhibiting drug. Moreover, our finding points to the importance of glomerular filtration in the renal handling of 99mTc-DMSA.
 ...
PMID:Reversible diminished renal 99mTc-DMSA uptake during converting-enzyme inhibition in a patient with renal artery stenosis. 632 98

Hippurate functional scintiscans were obtained in 51 hypertensive patients and in 15 controls. We investigated the influence that posture and exercise have on hippurate kinetics in patients with hypertension. A posture- or exercise-induced disturbance of renal hippurate transport was sought. All persons were examined in prone and standing positions, as well as during exercise. When prone and upright renograms were compared, 24% of the hypertensives demonstrated bilateral orthostatic renal dysfunction. Exercise caused the hippurate transport disturbance to increase. Fifty-seven percent of all hypertensives developed evidence of marked, bilateral, renal dysfunction during ergometric stress, so that exercise renography was shown to be a more sensitive test of the presence of transient tubular dysfunction in hypertension than the standing renogram. In normotensive controls the hippurate functional scintigram failed to be influenced by posture and exercise. The results suggest presence in hypertension of transient, posture- and exercise-mediated alterations of renal cortical blood flow.
 ...
PMID:The exercise renogram. A new approach documents renal involvement in systemic hypertension. 682 72

Hippurate function scintiscans were obtained in prone and standing positions in a group of 76 patients with concurrent hypertension and nephroptosis. TWelve of these patients had massive, bilateral disturbance of intrarenal hippurate transport in the standing position; hippurate transport was normal in the prone position. This pattern was present in only three of 120 normotensive patients with nephroptosis. To investigate the importance of nephroptosis, 87 other hypertensive patients were examined. Eighteen of these patients demonstrated posture-dependent tubular dysfunction, but only four had nephroptosis. The results suggest a direct relationship between bilateral posture-dependent tubular dysfunction and hypertension.
 ...
PMID:Hypertension associated with massive, bilateral, posture-dependent renal dysfunction. 724 30

Immunosuppression after transplantation is complicated by hypertension and nephrotoxicity, reflecting widespread vasoconstriction associated with CsA. FK506 is a novel alternative immunosuppressive agent, structurally unrelated to CsA. These studies compared systemic and renal vascular changes developing in the initial 4 weeks after liver transplantation in patients treated with FK506 (plus PRED) and CsA (plus PRED and AZA). We studied arterial pressure, cardiac index (pulsed doppler ultrasound), and systemic resistance index (SVRI) before and weekly after liver transplant in 32 patients treated with CsA (2 mg/kg initial dose plus PRED; median dose at week 4, 30 mg/day) and 14 patients treated with FK506 (0.15 mg/kg/day initial dose and PRED; mean week 4 dose, 12.5). Renal plasma flow and glomerular filtration rate (GFR) were measured by clearance of para-amino hippurate and 125-iothalamate. Renin activity, aldosterone, and urinary prostanoids were measured by RIA. Pretransplant pressures and hemodynamics reflected low SVRI and increased cardiac index typical of end-stage liver disease. After transplantation, SVRI and pressures rose in both groups, but after week 2, SVRI was lower in patients treated with FK506. This was associated with less prevalent clinical hypertension during the subsequent 4 months (4/14 FK506 (28%) vs. 25/32 (78%) CsA, P < 0.01). By contrast, renal blood flow and GFR fell in both treatment groups similarly, whereas renal vascular resistance rose. Urinary 6-keto-PG-F1-alpha was suppressed in all transplant recipients, but to a greater degree in FK506-treated patients. This value correlated directly to post-transplant GFR (r = 0.48, P < 0.001). These data indicate that FK506-based immunosuppression differs from CsA by inducing less systemic vasoconstriction and hypertension. Renal vasoconstrictive effects were at least as great as those seen with CsA, however, and indicate that nephrotoxicity will remain a common feature to both regimens.
 ...
PMID:Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. 768 34

The effect was studied of blood pressure lowering treatment on renal failure and albuminuria (UAE) in patients with type I diabetes (IDDM) and imminent nephropathy as well as in patients with over diabetic nephropathy. The group of 24 patients with imminent nephropathy was subdivided: 1. twelve patients with borderline or overt hypertension with mean BP lowered not below 100 mmHg, and 2. twelve patients with BP within the normal limits, taking no hypotensive agents. In the other group of 12 patients with overt diabetic nephropathy hypertension was lowered below 105 mmHg and kept so for at least two years. All patients estimated their glycemia and glycosuria by themselves, ate 0.8 g protein/kg/24 h and about 100 mmol Na/24h. Under hospital conditions the following were estimated: albuminuria, glomerular filtration rate (51Cr EDTA) and effective renal blood flow (131I hippurate). The same examinations were repeated 1 year and 2 years later. The lowering of BP below 100 mmHg in patients with imminent diabetic nephropathy significantly lowered microalbuminuria without changing GFR, ERPF despite good or satisfactory compensation of diabetes. Maintaining BP below 105 mmHg for 2 years did not prevent the patients with overt nephropathy to develop progressive renal failure despite the rate of GFR deterioration and of the increase of albuminuria slowed down.
 ...
PMID:[Effect of treatment of arterial hypertension on renal function in patients with imminent and overt diabetic nephropathy]. 773 1

Patients with advanced renal failure suffer from almost constant insulin resistance (IR) which is a major risk factor of atherosclerosis and very probably also of glomerulosclerosis. However, data on IR in kidney disease patients with mild-to-moderate kidney function decrease are lacking. A group of 52 patients with various kidney diseases and decreased kidney function of different degree but not with advanced renal failure was evaluated. Almost half of them suffered from IR though they did not differ from insulin-sensitive patients in age, sex, prevalence of various kidney diseases, hypertension, clearance of endogenous creatinine, serum creatinine, urea, uric acid, hippurate or pseudouridine concentrations. They did not differ in the prevalence and degree of metabolic acidosis or in the concentration of plasma and total and free magnesium in erythrocytes. They were just slightly more obese and their serum TG and VLDL concentrations were increased and HDL concentration decreased. It is concluded that IR and dyslipoproteinemia develop in the early stages of kidney diseases and could participate in kidney disease progression since the beginning of kidney disease. It is suggested that early treatment of these alterations could decrease the progression of kidney disease more effectively than their treatment in advanced stages.
 ...
PMID:The prevalence of insulin resistance in kidney disease patients before the development of renal failure. 775 61

We compared the effects of acute and chronic ACE inhibition (ACEi) on the 123I-hippurate in the stenotic kidney of two 2-kidney, 1-clip hypertensive dogs. In the period after clip implantation poststenotic renograms without ACEi of both dogs were normal. Acute ACEi always resulted in delayed hippurate handling. Chronic ACEi, however, induced abnormal poststenotic renograms in only 36% of the cases. Withdrawal of chronic ACEi restored the phenomenon of acute ACE-induced delayed hippurate handling within 5 months in both dogs. These data indicate that chronic ACEi or recent ACEi medication reduces the effectiveness of ACEi renography in diagnosing hypertension due to a moderate renal-artery stenosis. This phenomenon may explain why the sensitivity of ACEi renography in human studies varies more than in animal studies.
 ...
PMID:Effect of chronic ACE inhibition on the diagnostic value of renography for renovascular hypertension: a preliminary report. 775 62

Arterial hypertension contributes to the development of lipid abnormalities, as may also do so some antihypertensive drugs. Chronic hypercholesterolemia (HC) accelerates the atherosclerotic process, which in turn alters the vascular response to a variety of vasoactive agonists. Because of the cholesterol-membrane fluidity-ionic transport relationships, it is reasonable to propose that HC of short duration, unaccompanied by vascular morphologic changes, could first, alter vascular reactivity, and second, lead to early functional hemodynamic abnormalities. To answer these two questions, the following study was undertaken. HC was induced by feeding New Zealand rabbits a cholesterol (4%) and cholic acid (1%) enriched diet. The response to angiotensin II (10(-11) to 10(-8) M), of desendothelialized strips of aorta (A), mesenteric artery (MA) and vein (MV) obtained from rabbits fed during 1, 2, and 3 consecutive weeks, was examined using the cascade superfusion technique. HC fails to alter the aortic contractile response to angiotensin II. However, the MA contraction decreases by 48, 52, and 74% below baseline values (p < 0.01) after 1, 2, and 3 of HC. In contrast, the MV contraction is enhanced by 85, 87, and 22% above control values (p < 0.01) during the same periods of HC. In these animals, renal plasma flow (para-amino-hippurate clearance) decreased from 14.6 to 11.4, 8.8, and 9.3 ml/min (p < 0.01) after 1, 2, and 3 weeks of HC, while glomerular filtration rate (inulin clearance) similarly declined from 4.3 to 3.7 (NS), 2, 3, and 2.5 ml/min (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:[Effect of hypercholesterolemia on vascular reactivity: repercussions on renal hemodynamics in the rabbit]. 775 58


<< Previous 1 2 3 4 5 Next >>